Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A gene involved in certain types of intellectual disability regulates myelin sheath development

Published on: 03/02/2017 Reading time: 1 min
image
Retour à la recherche

Myelin, a protective sheath that covers various nerve fibers, is essential in the transmission of nerve signals and enables proper function of the nervous system. Myelin degeneration causes severe illnesses including multiple sclerosis. Lamia Bouslama-Oueghlani from the team led by Brahim Nait Oumesmar at Paris Brain Institute and collaborators proved that the Pak3 gene, involved in certain types of intellectual disabilities, regulates myelin sheath formation.

Myelin plays a critical role in nerve signal transfer as well as in axonal protection and support. It is necessary to ensure proper function of the nervous system, and myelin deficit is observed in severe pathologies including multiple sclerosis and leukodystrophy. Oligodendrocytes are the key cells in the development process.

Myelin and oligodendrocyte deficit is also described in several mental/psychiatric illnesses; recent studies highlighted the critical role played by myelin plasticity in cognitive and behavioral functions. Oligodendrocytes could therefore be targeted in neuropsychiatric pathologies including depression, autism and schizophrenia.

In this context, Pak3 is of particular interest. Several Pak3 genetic mutations were identified in mental illnesses with intellectual disability. PAK3 protein is expressed in the brain, where its action has mainly been studied in neurons but not in glial cells. However, Pak3 is expressed in oligodendrocytes and precursors, cells that are to become oligodendrocytes after differentiation and maturation.

For the first time, a research project involving the team led by Brahim Nait Oumesmar has focused on effects of a loss of function in gene Pak3 on oligodendrocyte and myelination development.

Researchers highlighted strong PAK3 protein expression in oligodendrocyte precursors, notably lowered in mature oligodendrocytes. The team found that loss of Pak3 function leads to poor differentiation of oligodendrocyte precursors and poor myelin sheath development is certain areas of the brain. However, it appears that in adults poor differentiation may be compensated by mature oligodendrocytes in terms of oligodendrocyte density as well as axon myelination.

Researchers also focused on the effects of lack of Pak3 at cellular level by comparing proliferation, migration and differentiation of oligodendrocyte precursor cultures with or without Pak3 expression. Results show that
PAK3 acts as a regulator of oligodendrocyte precursor differentiation.

The next step is studying how PAK3 acts on oligodendrocyte precursors, and understanding its involvement in mental and psychiatric illnesses.

Sources

https://pubmed.ncbi.nlm.nih.gov/27940202/
Maglorius Renkilaraj MR, Baudouin L, M Wells C, Doulazmi M, Wehrlé R, Cannaya V, Bachelin C, Barnier JV, Jia Z, Nait Oumesmar B, Dusart I, Bouslama-Oueghlani L.

Our news on the subject

Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
lauréat de la 3ème édition de l’appel à projets NeurAL
Brahim Nait Oumesmar, winner of the 3rd NeurAL call for projects
This year, NeurAL, Paris Brain Institute’s start-up studio, has selected a project by the researcher Brahim Nait Oumesmar that seeks to develop a remyelinating treatment for multiple sclerosis. The winner will benefit from personalized support and...
10.15.2025 Research applications
sequencage adn
Intellectual development disorders: two new genes under the microscope
A Franco-German international research team has identified two new genes that play a role in the onset of intellectual development disorders (IDD), also known as intellectual disabilities. Researchers have successfully developed two new types of test...
12.08.2025 Research, science & health
Troubles du Développement Intellectuel
The "RNU-Splice" project receives support from the health sponsorship of AXA Mutuals
Intellectual development disorders (IDD) affect 2 to 3 per cent of the population and are characterized by impaired cognitive functions, impacting learning. TDI thus has an impact on coping skills with implications for daily life and is a major...
10.08.2025 Support
See all our news